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Objective: In diabetes, beta cell mass is not static but in a constant process of cell death and 
renewal. Inactivating mutations in transcription factor 1 (tcf-1)/hepatocyte nuclear factor1a 
(hnf1a) result in decreased beta cell mass and HNF1A-maturity-onset-diabetes-of-the-young 
(HNF1A-MODY). Here we investigated the effect of a dominant-negative HNF-1A mutant (DN-
HNF1A) induced apoptosis on the regenerative capacity of INS-1 cells.  
 
Research design and methods: DN-HNF1A was expressed in INS-1 cells using a reverse 
tetracycline-dependent transactivator system. Gene(s)/protein(s) involved in beta cell 
regeneration were investigated by real-time quantitative RT-PCR, Western blotting, and 
immunohistochemistry. Pancreatic stone protein/regenerating protein (PSP/reg) serum levels in 
human subjects were detected by ELISA.   
 
Results: We detected a prominent induction of PSP/reg at gene and protein level during DN-
HNF1A-induced apoptosis. Elevated PSP/reg levels were also detected in islets of transgenic 
HNF1A-MODY mice and in the serum of HNF1A-MODY patients. The induction of PSP/reg 
was glucose dependent and mediated by caspase activation during apoptosis. Interestingly, the 
supernatant from DN-HNF1A-expressing cells, but not DN-HNF1A-expressing cells treated with 
zVADfmk, was sufficient to induce PSP/reg gene expression and increase cell proliferation in 
naïve, untreated INS-1 cells. Further experiments demonstrated that Annexin-V-positive 
microparticles (MPs) originating from apoptosing INS-1 cells mediated the induction of 
PSP/reg. Treatment with recombinant PSP/reg reversed the phenotype of DN-HNF1A-induced 
cells by stimulating cell proliferation and increasing insulin gene expression.   
 
Conclusion: Our results suggest that apoptosing INS-1 cells shed microparticles that  may 
stimulate PSP/reg induction in neighbouring cells, a mechanism that may facilitate the recovery 
of beta cell mass in HNF1A-MODY.   
 
 
aturity-onset diabetes of the young 
(MODY) is a familial form of non-
insulin dependent diabetes 
characterized by early onset of disease, 
autosomal dominant inheritance and insulin 
secretory defects (1). MODY type 3, results 
from mutations in the gene encoding 
transcription factor-1 / hepatocyte nuclear 
factor1a (tcf-1/hnf1a) (2), recently denoted as 
HNF1A-MODY. HNF1A belongs to a 
network of transcription factors controlling 
organ-specific gene expression during 
embryonic development and in adult tissues 
(3). Previous studies demonstrated that 
HNF1A is expressed in adult beta cells and 
regulates genes involved in glucose and lipid 
homeostasis as well as beta cell specific genes 
(4-10).  
Transgenic mice carrying a deletion of the 
hnf1a gene have defective glucose-stimulated 
insulin secretion without insulin resistance in 
target tissues (3), similar to individuals with 
HNF1A-MODY (11). Findings from animal 
and cellular models of HNF1A-MODY 
suggest a decline in functional beta cell mass 
as the primary mechanism of this defect (8; 
12; 13). Previous studies from our and other 
laboratories have shown that gene knock-out 
of HNF-1A or expression of DN mutants of 
HNF1Α (DN-HNF1Α) inhibits AKT 
signaling, decreases cell proliferation, and 
renders cells susceptible to apoptosis (8; 14; 
15). Evidence is growing that beta cell mass is 
M
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not static but in a constant process of cell 
death and renewal (16). However, it remains 
unclear in these models how increased beta 
cell apoptosis is linked to a compensatory 
stimulation of regenerative processes. 
The Regenerating (Reg) gene family belong 
to the calcium-dependent lectin gene 
superfamily (17). Pancreatic stone protein 
(PSP) was identified from extracts of calcified 
pancreatic concrements (18). Regenerating 
protein (reg) was independently identified in 
a screen of a regenerating islet-derived cDNA 
library taken from 90% depancreatized rats 
(19) and was found to be identical to PSP 
(20). Subsequent studies highlighted the 
potential role for the Reg gene family in 
pancreatic regeneration (21). We investigated 
the expression of the PSP/reg gene during 
DN-HNF1A-induced apoptosis and found 
PSP/reg to be prominently upregulated. We 
also provide biochemical evidence that 
apoptotic cells shed microparticles (MPs) that 
may stimulate PSP/reg induction in 
neighbouring cells, thereby linking beta cell 
apoptosis with beta cell regeneration.  
 
RESEARCH DESIGN AND METHODS 
INS-1 cells overexpressing HNF1A in an 
inducible system. Rat insulinoma INS-1 cells 
overexpressing wild-type HNF1A (WT-
HNF1A) or a dominant-negative mutant of 
HNF1A (DN-HNF1A) under control of a 
doxycycline-dependent transcriptional 
activator have been described previously (4; 
8). Cells were cultured in RPMI 1640 at 6 
mM glucose supplemented with 10% FBS 
(PAA, Cölbe, Germany), 2 mmol/l L-
glutamine, 1 mmol/l pyruvate, penicillin (100 
U/ml), streptomycin (100 μg/ml), 10 mmol/l 
HEPES (pH 7.4) and 50 μmol/l 2-
mercaptoethanol (Sigma, Dublin, Ireland). 
For experiments investigating glucose 
dependence of PSP/reg induction, expression 
of DN-HNF1A was induced for 24 h and 
continued for a further 2 h in medium 
supplemented with glucose at 3, 6, 12 and 18 
mmol/l. For caspase inhibition, cells were 
pre-incubated with 100 µmol/l of the broad-
spectrum caspase inhibitor zVAD.fmk 
(Bachem, St. Helen’s, UK) for 45 mins prior 
to induction.  
Real-time quantitative RT-PCR (qPCR).  
cDNA synthesis was performed using 1.5 μg 
total RNA as template and Superscript II 
reverse transcriptase (Invitrogen, Paisley, 
UK) primed with 50 pmol random hexamers 
(New England Biolabs, Ipswich, MA, USA). 
Real-time PCR was performed using the 
LightCycler 2.0 (Roche Diagnostics, 
Indianapolis, IN, USA) and the QuantiTech 
SYBR Green PCR kit (Qiagen). Specific PCR 
primers were designed using Primer3 
software (sequences available on request).  
For absolute quantification of hnf1a copy 
number a gene-specific PCR amplicon of 
known concentration was prepared as a 
standard. Melting curve analysis and gel 
electrophoresis was utilized to verify 
specificity of all PCR products. The data were 
analysed using LightCycler Software 4.0® 
with all samples normalized to β-actin.  
Western Blotting. For Western blotting 
analysis, 25 μg protein lysates were obtained 
from INS-1 cells overexpressing WT-HNF1A 
and DN-HNF1A as described (9). The rabbit 
polyclonal anti-PSP/reg antibody (22) was 
diluted 1:20,000 in Tris-buffered saline 
containing 1% bovine serum. The primary 
mouse monoclonal anti-β-actin antibody was 
utilized at a 1: 10,000 dilution (Sigma). HRP-
conjugated secondary antibodies were 
obtained from Pierce and detected using using 
SuperSignal West Pico Chemiluminescent 
Substrate (Pierce) and imaged using a 
FujiFilm LAS-3000 imaging system (Fuji, 
Sheffield, UK). 
Immunohistochemistry. Paraffin-embedded 
pancreatic sections from rat insulin promoter 
(RIP)-DN-HNF1A and control wild-type 
C57BL/6JBomTac mice (13) were 
deparaffinized and incubated overnight at 4 
°C with the rabbit polyclonal anti-PSP/reg 
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antibody diluted 1:20 (22). Specificity of the 
antibody was confirmed by Western blotting 
experiments using recombinant human 
PSP/reg protein as a control. Slides were 
incubated for 1 h at RT in Rhodamine labeled 
anti-rabbit secondary antibody (Jackson 
Immunoresearch, UK) (1:100). Slides were 
incubated again overnight at 4 °C with the 
second primary guinea pig anti-insulin 
antibody (DakoCytomation A0564; 1:20) 
followed by 1 h at RT in FITC labeled anti-
goat secondary antibody (Jackson 
Immunoresearch; 1:100) and mounted in 
Vectashield with DAPI (Vector Shield, 
Vector Labs; Burlingame, CA). Images were 
taken with a Zeiss LSM710 confocal 
microscope equipped with a 40 ×1.3NA oil 
immersion objective (Carl Zeiss, Jena, 
Germany). FITC was excited at 488 nm with 
an argon laser, using a 488/543 nm multi 
chroic beam splitter, the emission was 
collected at a 490- to 550-nm spectral band. 
Rhodamine was excited at 543 nm with a 
helium neon laser, using the same beam 
splitter, and the emission was collected at a 
570-650nm spectral band. DAPI was excited 
using the 405 nm DPSS laser, and a 405nm 
dichroic beam splitter. DAPI fluorescence 
was detected in the 420-480nm spectral band. 
Images were processed using Zeiss LSM 4.2 
software (Carl Zeiss, Germany). Rhodamine 
positive cells in the periphery and interior of 
the islet were quantified as a percentage of 
total islet cells using Image J software. 
Determination of caspase-3-like protease 
activity. INS-1 cells were seeded at 1 x 105 
per ml on a 24 well plate and allowed to settle 
overnight. Following treatment cells were 
lysed in 200 μl lysis buffer (10 mM Hepes, 
pH 7.4, 42 mM KCl, 5 mM MgCl2, 1 mM 
PMSF, 0.1 mM EDTA, 0.1 mM EGTA, 1 
mM DTT, 1 μg/ml pepstatin A, 1 μg/ml 
leupeptin, 5 μg/ml aprotinin, 0.5 % CHAPS). 
Fifty μl of this lysate was then added to 150 
μl reaction buffer (25mM Hepes, 1 mM 
EDTA, 0.1 % CHAPS, 10 % sucrose, 3 mM 
DTT, pH 7.5) containing 10 μM Ac-DEVD-
AMC which is efficiently cleaved by the 
apoptotic executioner caspases 3, and 7 
among others (23). Cleavage of the substrate 
DEVD-AMC resulting in the accumulation of 
fluorescent AMC was measured on a Genios 
fluorescence plate reader (Tecan) using 355 
nm excitation and 460 nm emission 
wavelengths as previously described (9). 
Protein content was determined using the 
Pierce Coomassie Plus Protein assay reagent 
(Perbio) and activity expressed as change in 
fluorescent units/µg of protein/ h. 
Detection of nuclear apoptosis. Cells were 
stained using DAPI to visualize nuclear 
morphology.  Condensed and/or fragmented 
nuclei were considered apoptotic and 
observed using an Eclipse TE 300 inverted 
microscope (Nikon, Dusseldorf, Germany) 
and a 20 x dry objective, with DAPI excited 
at 340 ± 25 nm and the emission collected 
between 450-500 nm.  
BrdU Cell Proliferation assay. Cellular 
proliferation was assessed by means of 
Bromodeoxyuridine (5-bromo-2-
deoxyuridine, BrdU) incorporation using the 
BrdU Cell Proliferation Assay (Calbiochem). 
BrdU was added to cells for 24 h and cells 
were fixed following treatment.  Following 
incubations with the primary and secondary 
antibodies the peroxidase labeled secondary 
antibody was detected by addition of substrate 
solution for 15 min and the reaction stopped.  
Absorbance was read using a Bio-Rad 550 
microplate reader at dual wavelengths of 
450/540 nm. The values for the background 
wells were subtracted from all values. The 
data was normalized to non-induced control. 
Microparticle Isolation and Purification. 
Cell supernatants were centrifuged (500 g; 15 
min) to remove floating cells and medium 
containing MPs released from INS-1 cells 
collected following an established protocol 
(24). The medium was filtered using 0.2 μm 
filters (VWR International, Dublin, Ireland) in 
order to remove MPs. MPs were analyzed on 
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a Coulter EPICS XL flow cytometer 
(Beckman Coulter, Villepinte, France) as 
previously described (25). Regions 
corresponding to MPs were identified in 
forward light scatter (FCS) and side-angle 
light scatter (SSC) dot plots using a 
logarithmic gain. The gate for MPs was 
defined as events with a 0.1-1 µm diameter, in 
comparison with calibrator beads (Megamix 
fluorescent beads of 0.5, 0.9 and 3 µm in 
diameter; Biocytex, Marseille, France), and 
plotted on a FL/FSC dot plot to determine the 
MPs. MPs were defined as membrane vesicles 
smaller than 1 μM in diameter and expressing 
externalized phosphatidylserine (PS). PS was 
labelled using Fluoroisothiocyanate-
conjugated Annexin V (Roche Diagnostics, 
France) in the presence or absence (negative 
control) of CaCl2 (5 mM) as reported earlier 
(25). 
Preparation of recombinant human 
PSP/reg protein. The recombinant human 
PSP/reg protein was generated as previously 
described (22; 26). Briefly, the coding region 
of PSP/reg was cloned into a transfer vector 
(pPIC9, Invitrogen) containing the signal 
sequence of the yeast α-mating factor to drive 
the protein into the secretory pathway.  
Subjects and clinical and laboratory 
measurements. Sixteen diabetic subjects with 
mutations in the HNF-1A gene (P291fsinsC, 
n=8 and p.Ser353fs, n=7) were identified 
from an Irish MODY collection. Sequencing 
of the HNF1A gene was performed by 
IntegraGen GmbH (Bonn, Germany). Control 
subjects were first degree relatives of HNF1A 
positive subjects who were non-diabetic and 
negative for the known HNF1A mutation in 
their pedigree (n=7). In addition, 10 GAD 
and/or islet antibody positive patients with 
type 1 diabetes were recruited in the Mater 
Misericordiae University Hospital. 
Anthropometric measurements including 
weight, height, and BMI were obtained. The 
plasma glucose concentration was measured 
using an YSI analyser (Roche, France). 
Haemoglobin A 1c was determined using 
HPLC (Menarini HA81-10,Italy). Anti-
glutamic acid decarboxylase (GAD) was 
analysed using competitive fluid phase RIA 
by the Neuroscience group in John Radcliffe 
Hospital, Oxford and Islet Cell Antibodies 
(ICA) by UCL Medical School, London by 
similar means. Study groups were matched 
for age sex and BMI as shown in Table 1 and 
approved by the Mater Misericordiae 
University Hospital Ethics committee. 
PSP/reg ELISA. The ELISA to quantify 
human PSP/reg was performed using anti-sera 
from rabbits and guinea pigs immunized with 
recombinant human PSP/reg protein as 
previously described (22; 27). Serum was 
prepared by centrifugation and the IgG were 
purified by affinity chromatography on 
Protein A columns. Subsequently, a sandwich 
ELISA was designed on 96-well ELISA 
plates. Antibody of the first species (Guinea 
pig) was coated to the bottom, blocked with 
BSA and aliquots of serum were then 
incubated for two hrs. After washing, 
antibodies of the other species (Rabbit) was 
incubated. Finally, a phosphatase coupled 
anti-rabbit IgG was used. Patient serum 
PSP/reg levels were compared with standard 
amounts of protein of recombinant human 
PSP/reg. 
Statistical Analysis. Results were expressed 
as means ± SEM. Statistical analysis was 
conducted using the SPSS v.15.0 software 
package for Windows (SPSS Inc.). 
Differences between treatments were 
analyzed by Student’s t-test, as well as one-
way analysis of variance (ANOVA) and 
subsequent Tukey’s tests. Non-parametric 
data were analyzed by Mann-Whitney U-test. 
Differences were considered to be significant 
at P<0.05. 
 
RESULTS 
The inducible expression of DN-HNF1A 
leads to a potent induction of PSP/reg 
mRNA and protein.  Inducible, dominant 
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negative suppression of HNF1A function in 
INS-1 cells reduces the expression of HNF1A 
target genes involved in glucose and lipid 
homeostasis (4), and induces a caspase-
dependent apoptosis (8). To investigate the 
relationship between DN-HNF1A expression, 
activation of apoptosis, and induction of the 
regenerative PSP/reg gene in particular, INS-
1 cells stably transfected with respective rtTA 
systems were induced to express either DN-
HNF1A or WT-HNF1A. We observed a time-
dependent induction of DN-HNF1A or WT-
HNF1A mRNA in the respective INS-1 cells 
(Fig. 1A). This correlated with a significant 
reduction in mRNA levels of pdh1, a known 
HNF1A target gene (7) in response to DN-
HNF1A expression but not WT-HNF-1A 
(Fig. 1B). Examination of the expression of 
the Reg family of genes in INS-1 cells 
demonstrated that DN-HNF1A led to a potent 
induction of the PSP/reg gene at 24 h (~ 15 
fold) and 48 h (~ 30 fold).  Induction of WT-
HNF1A for up to 48 h did not significantly 
regulate PSP/reg expression (Fig. 1C).  
We next investigated PSP/reg protein levels 
after induction of DN-HNF1A. Cleavage of 
PSP/reg converts the 16-kDa proteins into a 
14-kDa insoluble fibrillar protein (28). 
Western blot analysis demonstrated a 
significant upregulation of the PSP/reg 
protein (16 kDa) following DN-HNF1A 
induction, and a time-dependent increase in 
the 14 kDa form of PSP/reg (Fig. 1D).  
High extracellular glucose levels 
potentiates PSP/reg mRNA induction. We 
next determined whether the induction of 
PSP/reg mRNA was glucose dependent. 
Interestingly, we found that the DN-HNF1A 
induction of PSP/reg mRNA expression was 
modulated by varying extracellular glucose 
concentrations for 2 hr following DN-HNF1A 
induction. The increase in PSP/reg mRNA 
expression was potentiated in a concentration-
dependent with the highest induction evident 
at 18 mmol/l (Fig. 2A).  
Elevated PSP/reg levels in a HNF1A-
MODY animal model and in the serum of 
HNF1A-MODY patients. We analyzed 
paraffin-embedded pancreatic sections from 5 
month old diabetic (Fig. 2B) mice expressing 
DN-HNF1A in beta cells and compared them 
to wild-type C57BL/6JBomTac mice. 
Sections were co-stained for PSP/reg and 
Insulin. PSP/reg was expressed at low levels 
in wild-type islets (36 ± 1 PSP/reg positive 
cells per islet; n = 8 islets from n = 2 animals) 
and was found almost exclusively in 
peripheral islet cells. In contrast, DN-HNF1A 
islets showed significantly elevated PSP/reg-
positive islet cells (82 ± 2 PSP/reg positive 
cells per islet; n = 8 islets from n = 2 
animals). Moreover, PSP/reg positive cells 
were found to be widespread throughout the 
transgenic islets and were also detectable in 
insulin-negative islet cells. Strong expression 
was also observed in the surrounding acinar 
cells (Fig. 2B). Interestingly, high 
magnification analysis suggested that many 
islet cells with elevated PSP/reg 
immunoreactivity were positioned in the 
vicinity of cells displaying apoptotic nuclear 
morphology (Fig. 2C). 
We next sought to determine whether 
increased PSP/Reg1a levels could also be 
detected in HNF1A-MODY diabetic subjects. 
We analyzed serum PSP/Reg1a levels in a 
group of 16 diabetic subjects with HNF1A-
MODY using ELISA. Results were compared 
with serum levels in 7 HNF1A-MODY 
negative, non-diabetic family members. 
PSP/Reg1a levels were significantly elevated 
in HNF1A-MODY subjects (Fig. 2D). 
Interestingly, we also detected elevated 
PSP/Reg1a serum levels in the serum of 
patients with type 1 diabetes (n = 10 patients; 
Fig. 2D).   
Induction of PSP/reg mRNA and protein 
by DN-HNF1A function involves the 
activation of caspases. Previously we 
demonstrated that DN-HNF1A-induced 
apoptosis of INS-1 cells required caspases 
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and involved the activation of the 
mitochondrial apoptosis pathway (8). To 
assess whether the activation of executioner 
caspases influenced DN-HNF1A-induced 
PSP/reg mRNA induction, we first 
determined the time course of DEVDase 
activation (indicative of executioner caspase 
3/7 activity) by monitoring the cleavage of a 
fluorigenic caspase substrate. In agreement 
with our earlier report (8), there was a 
significant caspase activity in the time frame 
of 24-48 h post induction.  Expression of WT-
HNF1A or doxycycline treatment of parental 
INS-1 cells did not activate caspases (Fig. 
3A). Furthermore, DN-HNF1A induction 
mediated nuclear morphological changes 
indicative of apoptosis with condensation and 
fragmented nuclei. Pre-treatment with the 
pan-caspase inhibitor zVAD.fmk inhibited the 
occurrence of this apoptotic morphology 
confirming the caspase dependence (Fig. 3B). 
Given the similar kinetics of PSP/reg mRNA 
induction and caspase activation, we explored 
the possibility that caspase activation 
regulated PSP/reg expression.  Indeed, DN-
HNF-1A induction of PSP/reg expression was 
completely inhibited by pre-treatment with 
zVAD.fmk (Fig. 3C, D).  Next we addressed 
whether DN-HNF1A induction of PSP/reg 
mRNA could be sufficiently explained by its 
ability to activate apoptosis. Indeed, induction 
of apoptosis in INS-1 cells with the 
topoisomerase inhibitor, etoposide, was 
sufficient to increase PSP/reg mRNA levels 
in a caspase dependent manner (Fig. 3E). 
Conditioned medium from DN-HNF1A–
induced INS1 cells results in a prominent 
increase in PSP/reg mRNA expression in 
naïve INS-1 Cells. Executioner caspases such 
as caspase-3 inactivate transcription and 
translation processes (29), suggesting that 
apoptosing cells were unlikely to be the 
source of increased PSP/reg mRNA during 
DN-HNF1A-induced apoptosis. We 
investigated whether this increased expression 
was due to apoptosing cells sending a 
paracrine signal to neighbouring cells. After 
48 h of DN-HNF1A induction in the presence 
and absence of zVAD.fmk, the conditioned 
medium was added directly to naïve INS-1 
cells resulting in a 16 fold increase in PSP/reg 
mRNA levels in the naïve INS1-cells (Fig. 
4A). This induction was absent in cultures 
incubated with the conditioned medium of 
zVAD.fmk pre-treated DN-HNF1A-induced 
cells (Fig. 4A) or heat inactivated conditioned 
medium (Fig. 4B), supporting the hypothesis 
that apoptotic cells secrete (a) heat-sensitive 
factor(s) which stimulate(s) PSP/reg gene 
induction in neighbouring cells. 
Removal of Microparticles (MPs) inhibits 
PSP/reg gene induction. MPs are small (100 
nm) membrane vesicles, originating from 
blebbing membranes of apoptotic cells and 
can be identified by Annexin V staining. 
These MPs may contain nuclear proteins as 
well as nucleic acids (30; 31). We examined if 
MPs were present in our conditioned medium, 
and if so, whether these could modulate 
PSP/reg expression. After 48 h of DN-
HNF1A induction in the presence and 
absence of zVAD.fmk, we enriched for MPs 
in the supernatant (25) and applied either 
filtered or unfiltered medium to naïve INS-1 
cells for a further 24 h.  Naïve INS1-cells 
treated with the unfiltered conditioned 
medium from DN-HNF1A-induced cells had 
increased PSP/reg mRNA levels which was 
abolished by filtration of this conditioned 
medium, or by using unfiltered medium from 
DN-HNF1A-induced cultures in the presence 
of zVAD.fmk (Fig. 4C).  Importantly, flow 
cytometry identified increased MPs levels in 
the unfiltered compared with the filtered 
conditioned medium from the same 
experiment, indicating that MPs were not 
generated by the isolation procedure (Fig. 
4D).  Indeed, MPs were at least 150 fold more 
abundant in unfiltered compared to filtered 
conditioned medium with a significantly 
reduced level in zVAD.fmk pre-treated 
unfiltered medium (Fig. 4D).  These results 
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suggest that caspases are required for MP 
formation, and their removal abolishes the 
conditioned medium induced PSP/reg mRNA 
expression in naïve INS-1 cells.  
Treatment of INS-1 cells with recombinant 
PSP/reg protein reverses the DN-HNF1A-
induced decrease in cell proliferation and 
increases insulin mRNA levels. Animal 
models of diabetes have demonstrated that 
recombinant PSP/reg (rPSP/reg) increases 
beta cell mass and beta and ductal cell 
proliferation (21; 32). DN-HNF1A induction 
led to significant decreases in cell 
proliferation as detected by BrdU 
incorporation which was reversed by rPSP/reg 
treatment (Fig. 5A). Decreased cell 
proliferation has been attributed to DN-
HNF1A induced expression of the cell cycle 
inhibitor p27Kip1 (8; 9). Induction of DN-
HNF1A led to increased p27Kip1 mRNA 
expression, but did not affect p21WAF1 
expression (data not shown), with rPSP/reg 
co-treatment reducing DN-HNF1A induced 
p27Kip1 expression (Fig. 5C). Furthermore, the 
rPSP/reg treatment rescued the decrease in 
insulin gene expression induced by DN- 
HNF1A expression (Fig. 5B). Taken together 
our data suggest that rPSP/reg treatment 
reverses the DN-HNF1A induced phenotype. 
Indeed, BrdU incorporation was also 
significantly elevated in naïve INS-1 cells 
treated with conditioned cultured medium 
from DN-HNF1A induced cells compared to 
those induced in the presence of zVAD.fmk 
(Fig. 5D). 
 
DISCUSSION 
The present study provides evidence that beta 
cell apoptosis may stimulate beta cell 
regeneration. We demonstrate: (i) that 
dominant negative suppression of HNF1A 
leads to apoptosis and a potent induction of 
PSP/reg; (ii) this induction was potentiated by 
increased extracellular glucose 
concentrations; (iii) the induction of PSP/reg 
was inhibited by the broad-spectrum caspase 
inhibitor, zVAD.fmk, which also inhibited 
DN-HNF1A-induced apoptosis; (iv) 
conditioned medium from DN-HNF1A-
induced cells was sufficient to induce 
PSP/reg expression in naïve INS-1 cells, 
suggesting that apoptosing INS-1 cells secrete 
factors that stimulate PSP/reg induction in 
neighbouring cells; (v) removal of MPs from 
this conditioned medium inhibited PSP/reg 
induction, suggesting that MPs released from 
blebbing membranes mediated this effect; (vi) 
treatment of INS-1 cells with rPSP/reg protein 
reversed the DN-HNF1A-induced decrease in 
cell proliferation and insulin mRNA, (vii) 
moreover, PSP/reg serum levels were 
significantly elevated in HNF1A-MODY 
patients and type 1 diabetics compared to 
HNF1A-MODY-negative, non-diabetic 
family members.  
Regulation of beta cell mass in HNF1A-
MODY. Evidence is growing that functional 
beta cell mass is decreased in animal models 
of MODY and in type 2 diabetes, with an 
increased apoptosis rate largely contributing 
to this decrease (12; 13; 33). However, a 
decrease in beta cell mass does not 
necessarily implicate that new beta cells are 
not generated during disease progression. 
Indeed, beta cell mass is a result of a 
homeostatic balance between the generation 
of new beta cells and the rate of their 
apoptosis (34). As HNF1A-MODY and Type 
2 diabetes evolve over several years or 
decades, the destruction or apoptosis rate of 
beta cells may eventually exceed the rate of 
beta cell generation during disease 
progression.  
Although beta cell regeneration may occur 
during disease progression, it is not clear 
whether this happens through self-replication 
of mature beta cells, through neogenesis of 
progenitor cells residing in the pancreas or 
recruited from other tissues, or through 
transdifferentiation. Here we supply to our 
knowledge for the first time evidence that the 
interaction of beta cell apoptosis and 
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regeneration is more complex, and in fact that 
both processes may be mechanistically linked. 
In our study, we observed that DN 
suppression of HNF1A or apoptosis induced 
by genotoxic stress (etoposide) led to caspase-
dependent apoptosis of INS-1 cells, 
associated with the induction of the 
regenerative PSP/reg gene. Furthermore, 
conditioned medium from apoptosing cells 
was sufficient to stimulate PSP/reg mRNA 
expression and BrdU incorporation in naïve 
INS-1 cells. These findings allow for the 
conclusion that apoptosing beta cells secrete 
factor(s) that can stimulate regenerative gene 
induction and cellular proliferation in 
neighboring cells. Finally we demonstrate that 
administration of rPSP/reg reversed the DN-
HNF1A-induced decrease in cell 
proliferation; supporting the concept that beta 
cell replication may be positively regulated by 
beta cell apoptosis. The ability of apoptotic 
cells to provide signaling cues for their 
environment has been demonstrated in other 
settings, such as inhibition of inflammation. 
Interestingly, recent studies have 
demonstrated that caspase activation is 
required for tissue regeneration during wound 
healing and planarian regeneration (35; 36), 
suggesting that tissue regeneration in response 
to caspase-dependent apoptosis may be an 
evolutionary conserved process.  
PSP/reg: Biological effects and role in 
HNF1A-MODY. The Reg family of proteins 
constitute a multigene family in humans and 
rodents (19). PSP/reg increases beta cell mass 
and stimulates beta cell proliferation under 
physiological conditions and in 90% 
depancreatized and nicotinamide-injected rats 
(19; 37). Studies in mice lacking the gene 
Reg1, the mouse homologue of PSP/reg, 
revealed that Reg1 is involved in cell cycle 
progression and normal islet growth (37). 
Reg1 knockout mice have significant 
reductions in islet cell mass and rate of DNA 
synthesis in isolated islet cells (37; 38). We 
identified that rPSP/reg reversed the DN-
HNF1A induced upregulation of p27Kip1gene 
expression and the concomitant decrease in 
insulin expression. Previous studies have 
shown that PSP/reg induces ERK1/2 
signalling in MKN45 gastric cancer cells (39). 
However, the signal transduction pathways 
activated by PSP/reg in pancreatic islets 
warrant further investigation. Interestingly, 
we observed that elevated extracellular 
glucose concentrations rapidly potentiated 
PSP/reg gene expression. This may represent 
an important physiological feed-back loop for 
the regulation of beta cell mass. 
PSP/reg is physiologically secreted from 
pancreatic acinar cells (20). In the adult rat, 
PSP/reg has been shown to be present only in 
small amounts in beta cells (20; 40).  We 
detected increased expression of PSP/reg in 
insulin-positive islet cells in 5 month old 
transgenic HNF1A-MODY mice, confirming 
previous findings that PSP/reg is expressed in 
islets during injury and regeneration processes 
(17; 19). Moreover, PSP/reg was also found 
in insulin-negative islet cells (Fig. 2B). In this 
context, a recent study has suggested alpha 
cells to be the major source of beta-cell 
regeneration/conversion in mice in vivo (41). 
We also detected increased PSP/reg levels in 
the serum of HNF1A-MODY patients. We 
can only speculate whether the source of 
PSP/reg in the serum of HNF1A-MODY 
patients was the endocrine or exocrine 
pancreas, i.e. islet or acinar cells. We can 
likewise not exclude that these levels came 
from other organs potentially affected in 
HNF1A-MODY such as the liver where 
PSP/reg is also expressed (42). However, we 
also detected elevated levels of PSP/reg in 
subjects with Type 1 diabetes, arguing for a 
role for pancreatic injury and beta cell 
apoptosis as a source for elevated PSP/reg 
serum levels. 
Microparticles as signal transducers or 
enablers. In our study we detected that 
apoptotic INS-1 cells released Annexin V-
positive MPs into the medium in a caspase-
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dependent manner. MPs are being 
increasingly described as efficient vehicles for 
the release of signaling molecules. MPs 
enable communication between different cell 
types (43), and also deliver proteins to cells 
that do not normally express them (44). MPs 
deriving from apoptotic cells have been 
shown to carry nuclear proteins as well as 
nucleic acids (31; 45). Filtration experiments 
suggested that the absence of MPs abolished 
the effect of the conditioned medium to 
induce PSP/reg mRNA in naïve INS-1 cells. 
This suggested that cytokines, peptide 
hormones or other soluble messengers present 
in the conditioned medium did not mediate 
this effect. Interestingly, heat inactivation of 
the conditioned medium was sufficient to 
inhibit PSP/reg mRNA expression in naïve 
INS-1 cells. It is therefore tempting to 
speculate that MPs may contain signaling 
molecules or nuclear proteins which, upon 
uptake by neighboring cells, enhanced 
PSP/reg gene expression in these cells.  
 
CONCLUSION 
In conclusion, our study demonstrates that the 
execution of caspase-dependent apoptosis in 
INS-1 cells stimulates the induction of 
regenerative genes in neighboring cells, 
suggesting a role for MPs and PSP/reg in this 
process. These findings provide new 
mechanistic insights into a fundamental 
aspect of beta cell mass regulation.  
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Figure Legends  
 
Figure 1: The inducible expression of DN-HNF1A leads to a potent induction of PSP/reg 
mRNA and protein. (A) The time-course of hnf1a gene induction in DN-HNF1A and WT-
HNF1A induced INS-1 cells, represented by absolute quantitative PCR (qPCR). Data are 
presented as cDNA copy number per µl of the hnf1a gene expression. Data are represented as 
means ± SEM from n = 3 cultures. The experiment was repeated 3 times with similar results.* 
p<0.05 indicates the difference from non-induced controls. 
(B) Quantification of pyruvate dehydrogenase kinase (Pdk1) gene expression. DN-HNF1A 
and WT-HNF1A INS-1 cells were induced with doxycycline from 0 to 48 h. Pdk1 mRNA 
expression was examined using real-time qPCR relative to β-actin. Data shown are the means ± 
SEM of n=3 cultures. The experiment was repeated 4 times with similar results.* p<0.05, 
difference from non-induced controls. (C) Quantification of PSP/reg gene expression 
following DN-HNF1A and WT-HNF1A induction in INS-1 cells. INS-1 cells were treated 
with 500 ng / ml doxycycline from 0 to 48 h. mRNA expression of PSP/reg was examined using 
real-time qPCR relative to β-actin. Expression levels were normalized to control cells and data 
represent means ± SEM from n = 3 cultures.* p<0.05 difference from non induced controls. 
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Experiments were repeated 6 times with similar results (D) Whole cell lysates (25 μg) were 
analysed by Western blotting on 15% SDS-PAGE. Membranes were probed with a polyclonal 
antibody recognizing PSP/reg. The 14 kDa fragment represents a PSP/reg cleavage product. β-
actin served as a loading control. Approximate molecular weights are provided on the right side 
of the figure. Similar results were obtained in two separate experiments.  
Figure 2: High extracellular glucose potentiates PSP/reg mRNA induction in DN-HNF1A 
expressing INS-1 cells. (A) INS-1 cells were induced to express DN-HNF1A for 24 h. Cultures 
were continued for 2 h at either 3, 6, 12 and 18 mmol/l glucose concentrations. After this period, 
mRNA expression of PSP/reg was analyzed by real time qPCR. Expression levels were 
normalized to non-induced control cells and data are represented as means ± SEM from n = 3 
cultures.*p<0.05 for difference from non induced controls; # p<0.05, difference from induced 
cultures at 3 mmol/l glucose. Experiment was repeated 3 times with similar results. (B) PSP/reg 
immunoreactivity in islet cells in an in vivo mouse model of DN-HNF1A-induced apoptosis. 
Paraffin-embedded pancreatic sections on slides from 5 month old wild-type C57BL/6JBomTac 
control mice and RIP-DN-HNF1A transgenic mice were double stained using antibodies against 
PSP/reg and Insulin. Primary antibodies were recognised by secondary antibodies coupled to 
Rhodamine (red) for PSP/reg and to FITC (green) for insulin respectively. Cell nuclei were 
stained with DAPI (blue). Bar = 10 μm. (C) PSP/reg immunoreactivity in islets cells in 
proximity to cells showing apoptotic nuclear morphology.  High magnification images of 
PSP/reg immunoreactivity and DAPI staining in islets of DN-HNF1A mice. Arrows indicate 
cells exhibiting apoptotic nuclear morphology. Bar = 10 μm. (D) PSP/reg protein is detectable 
in the serum of HNF1A-MODY subjects and type 1 diabetics. Serum from HNF1A-MODY 
patients, their MODY-negative family members and type 1 diabetes patients were analyzed by a 
specific ELISA detecting human PSP/reg. The square indicates the normal range (Rolf Graf, 
historic data). Individual values, the average as well as the standard deviation are plotted. 
PSP/reg levels in HNF1A-MODY and type 1 diabetics were significantly different from MODY-
negative, control family members (* p<0.05). 
Figure 3: Activation of caspases during DN-HNF1A induced apoptosis triggers PSP/reg 
induction. (A) Time course of caspase-3-like protease activity in whole cell extracts. INS-1 cells 
were induced to overexpress WT-HNF1A or  DN-HNF1A for 0, 16, 24 and 48 h. As a control, 
parental INS-1 cells were treated with doxycycline for 0, 16, 24 and 48 h. Caspase protease 
activity was measured by cleavage of the fluorigenic substrate Ac-DEVD-AMC (10 µM). 
Activities are represented as increase in AMC fluorescence (in A.U.) per 1 h per µg of protein. 
Data represent means ± SEM from n=6 cultures. Experiments were repeated 2 times with similar 
results.* p<0.05 difference from non induced controls. (B) Treatment with the broad spectrum 
caspase inhibitor zVAD.fmk (100 µM) inhibits apoptosis after induction of DN-HNF1A. 
Cultures were simultaneously pre-treated with doxycycline and zVAD.fmk or vehicle 
(dimethylsulfoxide; zVAD.fmk) for 48. Apoptotic cell morphology was assessed by DAPI 
staining of nuclear chromatin. (C) zVAD.fmk inhibits PSP/reg mRNA induction. The mRNA 
expression of PSP/reg was examined using real-time qPCR. Expression levels were normalized 
to non-induced plus non-induced zVAD.fmk treated control cells. Data are represented as means 
± SEM from n = 3 cultures.* p<0.05 for difference from non-induced controls. # p<0.05, 
difference compared to doxycycline alone treated cultures. The experiment was repeated three 
times with similar results. (D) PSP/reg protein expression was detected by Western blotting. A 
duplicate experiment showed similar results. Membrane was stripped and reprobed with anti- β-
actin as a loading control. (E) PSP/reg gene induction in parental INS-1 cells treated with 
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etoposide is caspase dependent. INS-1 cells were simultaneously treated with etoposide (3 μM) 
or vehicle (0.1% DMSO) for 24 h in the presence and absence of zVAD.fmk (100 μM). 
Following treatment, mRNA expression of PSP/reg was examined using real-time qPCR. 
Expression levels were normalized to control cells. Data are represented as means ± SEM from n 
= 3 separate cultures.* p<0.05 for difference from non induced controls. # p<0.05, difference 
compared to etoposide alone treated cultures. Data shown are the mean of n=3 separate 
experiments.  
Figure 4: Conditioned medium from DN-HNF1A-induced INS1 cells results in a prominent 
increase in PSP/reg mRNA expression in naïve INS1 Cells. (A) INS-1 cells were induced with 
500 ng/ml of doxycycline in the presence and absence of zVAD.fmk (100 µM) at 0.05% serum 
in 6 mM glucose for 48 h. The conditioned culture medium was added to the non-induced, naive 
cells for a further 24 h. After treatment, mRNA expression of PSP/reg was analyzed by real-time 
qPCR. Expression levels were normalized to non-induced controls. Data are represented as 
means ± SEM from n = 3 cultures.* p<0.05 for difference from non induced controls; # p<0.05, 
difference from doxycycline alone treated cultures. Experiments were repeated 6 times with 
similar results. (B) Duplicate experiments of INS-1 cells were induced for 48 h Conditioned 
culture medium was heat-inactivated at 95 °C for 15 minutes and added to the naive cells for a 
further 24 h. PSP/reg gene expression was analyzed by real-time qPCR. Data are represented as 
means ± SEM from n = 3 cultures.* p<0.05 for difference from non induced controls. 
Experiments were repeated 4 times with similar results. (C) The conditioned medium from cells 
treated as described in (A) above was centrifuged and filtered through 0.20 µM filters and added 
to naïve INS-1 cells for 24 h. Unfiltered conditioned medium served as a control. PSP/reg gene 
expression was analyzed by real-time qPCR. Data are represented as means ± SEM from n =3 
cultures.* p<0.05 for difference from non induced controls. Experiments were repeated 3 times 
with similar results. (D) INS-1 cells were induced with doxycycline in the presence and absence 
of zVAD.fmk. The conditioned culture medium was added to naive cells for a further 24 h. 
Supernatants were collected and detached cells were precipitated at (300 X g), followed by 
additional 800 X g centrifugation. MPs were quantified as described in Materials and Methods.  
Figure 5: Treatment of INS1 cells with recombinant PSP/reg protein reverses the 
phenotype of HNF1A-MODY cells. 
(A) INS-1 cells were induced to express DN-HNF1A for 24 h before being cultured for a further 
24 h in the presence and absence of 10 ng/ml of rPSP/reg for 24 h. Proliferation was assessed by 
BrdU incorporation into the cells. Data are a mean ± SEM from n=6 cultures. Experiments were 
repeated 3 times with similar results.* p<0.05 for difference from non induced controls. 
#p<0.05, difference compared to doxycycline alone treated cultures. (B, C) DN-HNF1A INS-1 
cells were treated as described in (A) above. Insulin (B) and p27Kip1 (C) gene expression was 
analyzed by real-time qPCR. Data are represented as means ± SEM from n = 3 cultures.* p<0.05 
for difference from non induced controls. #p<0.05, difference compared to doxycycline alone 
treated cultures. Experiments were repeated 3 times with similar results. (D) The supernatant of 
apoptosing INS-1 cells induced by DN-HNF1A overexpression is sufficient to stimulate cell 
proliferation in naïve INS-1 cells. Cells were induced with 500 ng / ml of doxycycline in the 
presence and absence of zVAD.fmk (100 µM) in 0.05% serum at 6 mM glucose for 48 h. The 
conditioned culture medium was added to the non-induced, naive cells for a further 24 h. After 
treatment, cell proliferation was assessed by BrdU incorporation. Data are a mean ± SEM from 
n=6 cultures. Experiments were repeated 3 times with similar results.* p<0.05 for difference 
from non induced controls. #p<0.05, difference compared to doxycycline alone treated cultures. 
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Table 1.  Summary of the study groups used for ELISA measurement of PSP/reg levels. Patients 
were age, sex and BMI matched. Data is represented as mean +/- SEM.  * p<0.05 compared to 
HNF-1A MODY negative group.   
 
Group 
HNF 1A-MODY HNF 1A-MODY 
Negative 
T1DM p value 
N 16 7 10  
Sex (F:M) 10:6 4:3 6:4  
Age (years) 35.8±20 27.9±11 31.8±4.9 n.s. 
BMI (kg/m²) 24.4±4 26.6±7.9 25.5±1.3 n.s. 
HbA1c (%) 7.6±0.3* 5.4±0.3 7.8±0.3* *p<0.05 
PSP (ng/ml) 18.8±2.7* 8.3±3.8 17.3±1.7* *p<0.05 
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